Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis
SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) — Bionano Laboratories, a clinical laboratory services business of Bionano Genomics, Inc. (Nasdaq:…
Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) — Bionano Laboratories, a clinical laboratory services business of Bionano Genomics, Inc. (Nasdaq:…
IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it…
Further Advances SIGA’s Strategy to Expand Access to TPOXX into More International MarketsNEW YORK, June 17, 2024 (GLOBE NEWSWIRE) —…
Ian Taylor, Ph.D. President of Research and Development at Arvinas, Inc. Angela Cacace, Ph.D. Chief Scientific Officer at Arvinas, Inc.…
WATERTOWN, Mass., June 17, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing…
Spur Therapeutics Launch Video With a mission to redefine what gene therapy can do, Spur is optimizing every component of…
WINSTON-SALEM, N.C., June 17, 2024 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage…
Takeda’s Skyline study in Dravet syndrome narrowly missed its primary endpoint of reduction in convulsive seizure frequency and showed clinically…
Elritercept continued to demonstrate a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden Durable…
VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse…